Clinical Trials Logo

Filter by:
NCT ID: NCT05831930 Recruiting - HNSCC Clinical Trials

The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma

Start date: January 17, 2023
Phase: Early Phase 1
Study type: Interventional

For patients with locally advanced head and neck tumors who are over 70 years old, have PS>2, have hearing impairment, renal dysfunction, or have neuropathy greater than grade 1 that is intolerant to cisplatin, radiotherapy alone or combined with EGFR monoclonal antibody radiotherapy should be chosen. The purpose of this study is to demonstrate the superior efficacy of Nitozumab and Sinilimab when added to radiotherapy in the treatment of high-risk participants with resected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) who are ineligible to receive cisplatin-based chemoradiation concurrently.

NCT ID: NCT05831917 Recruiting - HNSCC Clinical Trials

MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

Recently developed hybrid machines (MRidian®-CE approval since 2016), consisting of a linear accelerator and an integrated low-field MRI, could allow better visualization of tumor and organs at risk during patient positioning and daily treatment finally repetitive adaptation of target volumes according to changes in patient weight and tumor anatomy during the radiotherapy course. These procedures would facilitate a high-precision treatment and help reduce dose exposure of critical structures.

NCT ID: NCT05831878 Recruiting - Clinical trials for Advanced Breast Cancer

RC48-ADC in HER2-low Advanced Breast Cancer

Start date: May 4, 2023
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of Disitamab vedotin (RC48-ADC) as salvage treatment in patients with HER2-low advanced breast cancer who have received up to one previous chemotherapy for recurrent or metastatic disease without previous use of antibody-drug conjugate.

NCT ID: NCT05831865 Recruiting - Clinical trials for Diffuse Large B Cell Lymphoma

Frontline of ASCT in High-risk DLBCL

Essential
Start date: May 3, 2023
Phase:
Study type: Observational

The role of frontline therapy of autologous stem cell transplant (ASCT) in diffuse large B-cell lymphoma (DLBCL) is controversial. The investigators aim to conduct this prospective study to observe the efficacy and safety of ASCT as frontline therapy in DLBCL patients with high-risk disease, defined by an International Prognostic Index (IPI) score equal to or greater than three.

NCT ID: NCT05831826 Recruiting - Autoimmune Diseases Clinical Trials

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

Start date: June 1, 2020
Phase:
Study type: Observational

According to the comprehensive evaluation, the completion of vaccination and the prevention and treatment strategy of integrated traditional Chinese and western medicine have obvious advantages in improving the symptoms of infection in patients with autoimmune diseases, shortening the course of disease and controlling disease activity, and can play a positive role in the whole process of epidemic prevention and treatment. Now the investigators plan to conduct multi-center clinical and basic research to observe the preventive effect and safety of the vaccine on COVID-19, as well as the preventive effect of the combination of traditional Chinese medicine, in order to obtain high-quality evidence-based evidence and provide scientific basis for the clinical value of the drug.

NCT ID: NCT05830877 Recruiting - Primary Insomnia Clinical Trials

The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia

Start date: May 10, 2023
Phase: N/A
Study type: Interventional

Through the recruition of outpatients who clinically meet the diagnostic criteria and inclusion criteria of PI, the acupuncture group adopts Tiaoshen acupuncture, and the placebo acupuncture group adopts non-insertive acupuncture supported by the Park device, and the Pittsburgh Sleep Quality Index (PSQI) is used as the main index to evaluate the patients through the scale; subjective indicators like Chalder 14-item fatigue scale, Epworth sleepiness rating, self-rating anxiety scale (SAS), self-rating depression scale (SDS) and objective indicators like polysomnography (PSG), heart rate variability (HRV) is regarded as a secondary index, and then evaluate the clinical efficacy of Tiaoshen acupuncture on PI and explore its mechanism.

NCT ID: NCT05830812 Recruiting - Clinical trials for Lung Adenocarcinoma, Stage I

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Start date: January 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to improve the intraoperative diagnosis accuracy of invasiveness for small-sized lung adenocarcinoma by combining multi-modal information. The main question it aims to answer is whether multi-modal information have great value of prediction on the invasiveness for small-sized lung adenocarcinoma. Since a promising limited resection is largely based on intraoperative frozen section diagnosis, there is a growing demand on the high-accuracy of timely pathology diagnosis. The multi-modal information of participants will be collected retrospectively.

NCT ID: NCT05830500 Recruiting - Clinical trials for Medullary Thyroid Cancer

Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

Start date: June 19, 2023
Phase: Phase 4
Study type: Interventional

This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in patients with advanced medullary thyroid carcinoma, and to summarize the treatment experience in a broad population of patients.

NCT ID: NCT05830240 Recruiting - Clinical trials for Head and Neck Cancer

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Start date: March 27, 2023
Phase: Early Phase 1
Study type: Interventional

9 participants are expected to be enrolled for this open,single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with relapsed/refractory head and neck cancer.

NCT ID: NCT05830227 Recruiting - Clinical trials for Infrared-thermal-imaging

Evaluation of Infrared Thermal Imaging in Diagnosis of OSAHS in Children

Start date: April 2023
Phase:
Study type: Observational

OSAHS is a common sleep breathing disorder in children, with the same incidence as childhood asthma, and is mainly caused by upper airway stenosis caused by tonsil/adenoid hyperplasia. Clinical findings show that children with OSAHS often present rhinitis symptoms and like rubbing eyes, but there is no evidence to suggest a correlation. Children with OSAHS suffer from recurrent hypoxemia during sleep, and the existing detection methods such as lateral nasopharyngeal radiographs and electronic nasopharyngoscopy can only reflect the structural and morphological changes of the oral, nasal and pharyngeal tissues, but cannot prove their functional status. Previous studies have found that infrared thermal imaging can reflect the oral, nasal and pharyngeal inflammation of patients, and the infrared expression of patients' frontal region and eyes can also reflect the physiological changes caused by sleep deprivation.